Precision IVF tracks how mouse embryos switch on their genome
A new study from EMBL Rome shows how embryos precisely coordinate gene activity during early development. The research is published in the journal Science Advances.
A recent study published in Science Advances reveals how mouse embryos precisely coordinate gene activity during early development through a process called embryonic genome activation (EGA). The research, conducted by Ana Boskovic's team at EMBL Rome, employed a precision in vitro fertilization (IVF) protocol to monitor gene activity in individual embryos at various time points. This allowed for an unprecedented high-resolution view of EGA.
The study found that even morphologically identical embryos can exhibit significantly different RNA landscapes depending on slight differences in their developmental timing. As EGA progresses, maternal RNA is gradually depleted, and the embryo's own genome becomes increasingly active. This switch is marked by an increase in gene expression related to RNA production, protein synthesis, and ribosome construction.
Additionally, the research uncovered the role of a specific histone modification called H3K4me3 in regulating gene expression during EGA. However, premature removal of this modification did not accelerate genome activation or impair blastocyst formation, suggesting that H3K4me3 alone is not responsible for maintaining genome silence. Instead, the findings indicate that the process of genome activation is a coordinated and flexible phenomenon, involving multiple molecular mechanisms rather than a single trigger.
Written by urgent.news from Phys.org's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
